“By creating an independent research Institute and including significant patient safeguards, the CER provisions will ensure that relevant, credible data is available to patients and their healthcare providers, and help ensure that information is used to inform treatment options, not limit them,” Mr. Coelho said.
Sen. Baucus’s measure includes expanded patient safeguards including a focus on clinical effectiveness research, not cost-effectiveness; and provisions to ensure that the Centers for Medicare and Medicaid Services will not misuse CER results in ways that overlook differences in patient needs or discriminate against the elderly or people with disabilities.
“The most important stakeholder in the medical community is the patient,” Mr. Coelho said. “Sen.
Baucus’s proposal puts patients at the center of comparative effectiveness research, providing assurance that research will be focused on improving patient care and not cutting costs by restricting access to treatment options.”
PIPC also supports similar legislation (H.R. 2502) that has been introduced in the House by Rep. Kurt Schrader and 18 cosponsors, and an amendment, proposed by Delegate Christensen, that is currently pending before the Energy and Commerce Committee.
The Partnership to Improve Patient Care was formed in November 2008 to support new comparative effectiveness research proposals that are centered on patient and provider needs; raise awareness about the value of well-designed CER; and promote the important role of continued medical innovation as part of the solution to cost and quality challenges in health care. Partnership members include a wide range of healthcare organizations representing patient, provider and industry advocacy groups.